News

Pfizer Inc. (NYSE:PFE) ranks among the best set-it-and-forget-it stocks to buy. On June 26, Pfizer Inc. (NYSE:PFE) declared ...
Columnist Joe MacDonald describes his early adjustments to cope with the reality of his oldest son's hemophilia.
Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my ...
The 10 men with severe hemophilia B received a single dose of scAAV2/8-LP1-hFIXco vector, administered through a peripheral vein, in three dose cohorts (low dose: 2×10 11 vector genomes [vg]/kg ...
While packing for a move, the youngest son of columnist Cazandra Campos-MacDonald experiences a regular guest: joint pain.
A new study found that patients with hemophilia A could safely switch directly from emicizumab to Mim8 without a washout period, meaning they did not need to stop treatment before starting the new ...
State Medicaid leaders create a plan to ensure safety, affordability, and equitable access for children and families living ...
Like many with hemophilia, columnist G Shellye Horowitz requires IV infusions of her medication — but the scars can raise some eyebrows.
Certain immune markers in the blood may help predict ITI response among hemophilia A patients given immune tolerance ...
Among the 83 appointees in 2025 are Albert Friesen and Kathy Mulder, both from Winnipeg, as well as Steinbach's Miriam Toews.
Changing how biopharmas package their products, how regulators review new drugs and how mutated genes are fixed could make ...